First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics IRE Technology at Australia’s The Alfred Hospital

QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO) announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case, at The Alfred in Melbourne, Australia. Using the NanoKnife™ system, Dr. Ken Thomson, Professor and Director of the Department of Radiology at The Alfred, Monash University, performed the procedures, which were judged by The Alfred to be successful from a safety perspective. The hospital will conduct further patient follow-up before determining final outcomes in terms of tumor response.